Fundraising Fox
/Companies
Sign in

Kindling Bio

London, GB · Founded 2025 · 2 employees on LinkedIn · 1 known investors

Find your way into Kindling Bio

Sign up to see every warm intro you have to Kindling Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Kindling Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Kindling Bio develops targeted cancer gene therapy for children that uses the immune system to fight a range of tumors. The company focuses on pediatric oncology, aiming to replace toxic adult-designed therapies with treatments tailored to children's biology.

BiotechHealthtech

Founders & leadership

Kindling Bio was founded in 2025 by Jeff Drew and Aleck Jones.

JDJeff Drew
Jeff DrewCo-FounderJeff Drew, founder of Kindling Bio, has more than 30 years of experience spanning virology, molecular biology, immunology, and stem cell research, including 23 years in industry. He has led programs from discovery through clinical-stage vaccine development and GMP manufacturing, contributed to over 100 patent filings, and previously provided scientific leadership to an oncology therapy company. Kindling Bio develops targeted gene therapy for pediatric cancers that harnesses the immune system to treat a range of tumors.
AJAleck Jones
Aleck JonesCEO, Co-founderBefore co-founding the company, he was a Founder in Residence at Deep Science Ventures, working on immune strategies for paediatric oncology, and held postdoctoral research positions at King's College London, UCL and the MRC National Institute for Medical Research. He is also an Honorary Research Associate at Imperial College London.

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
KINDLING BIO LTD
Company number
16308967
Status
Active
Company type
Private limited company
Incorporated
11 Mar 2025
Registered office
Innovation Gateway, The London Cancer Hub, Cotswold Road, Sutton, London, SM2 5NG
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 31 Mar 2026 · next due 31 Dec 2027
Confirmation statement
last made up to 10 Mar 2026 · next due 24 Mar 2027

Current officers · 3

  • Jeffrey Drew — director, appointed 11 Mar 2025
  • Aleck William Evan Gregory Jones — director, appointed 11 Mar 2025
  • Deep Science Ventures — corporate director, appointed 25 Nov 2025

Source: Companies House public register · retrieved 27 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Kindling Bio do?
Kindling Bio develops targeted cancer gene therapy for children that uses the immune system to fight a range of tumors. The company focuses on pediatric oncology, aiming to replace toxic adult-designed therapies with treatments tailored to children's biology.
Who founded Kindling Bio?
Kindling Bio was founded by Jeff Drew, Aleck Jones in 2025.
Who are Kindling Bio's investors?
Kindling Bio's investors include Deep Science Ventures.
Where is Kindling Bio headquartered?
Kindling Bio is headquartered in London, GB.